AI becoming core infrastructure for pharmaceutical R&D, not just an experimental tool: Report
Aug 08, 2026
Artificial intelligence (AI) is rapidly becoming a core part of pharmaceutical research and development (R&D), moving beyond its role as an experimental technology to...